Jiangsu Nanfang Medical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 599.66 million compared to CNY 544.78 million a year ago. Revenue was CNY 600.1 million compared to CNY 545.37 million a year ago.

Net loss was CNY 147.42 million compared to CNY 14.65 million a year ago. Basic loss per share from continuing operations was CNY 0.51 compared to CNY 0.05 a year ago. Diluted loss per share from continuing operations was CNY 0.51 compared to CNY 0.05 a year ago.